Masimo CORP 8-K filings

Masimo Corporation has been acquired by Danaher Corporation, with shares converted to $180.00 cash per share.

Masimo Corporation's shareholders have overwhelmingly approved the merger agreement with Danaher Corporation, paving the way for the acquisition.

Masimo Corporation has filed supplemental disclosures to its definitive proxy statement regarding the pending merger with Danaher Corporation to address ongoing stockholder litigation.

Masimo Corporation has entered into a definitive agreement to be acquired by Danaher Corporation for $180.00 per share in cash, totaling approximately $9.9 billion.

Masimo Corporation announced preliminary Q4 and full-year 2025 financial results, showing robust revenue growth and non-GAAP EPS at the high end of guidance.

Masimo Corporation reaffirmed its 2025 financial guidance and announced long-range targets through 2028, emphasizing strategic growth in patient monitoring and innovation.

Masimo Corporation has successfully refinanced its existing credit agreement, securing a new $1 billion unsecured credit facility comprising a term loan and revolving commitments.

Masimo Corporation reported strong third-quarter 2025 financial results, exceeding prior year performance and raising its full-year guidance despite new tariff impacts.

Masimo Corporation has completed the sale of its consumer audio business, Sound United, to Harman International Industries for approximately $328 million in cash, using a significant portion of the proceeds to repay a $270 million term loan.

Masimo Corporation has completed the sale of its Sound United consumer audio business to HARMAN International for approximately $328 million in cash, focusing on its core healthcare operations.

Masimo Corporation announced the resignation of Board Director William Jellison, effective August 18, 2025, with no reported disagreements.

Masimo Corporation reported strong second quarter 2025 financial results, driven by core healthcare business growth and effective tariff mitigation, while updating its full-year guidance.

Masimo Corporation has announced several senior leadership appointments aimed at strengthening its team and improving commercial excellence, alongside the resignation of its Chief Operating Officer.

Masimo Corporation announced it expects its recent cybersecurity incident to have no material impact on its fiscal year 2025 revenue, with operations largely restored and remediation costs covered by insurance.

Masimo Corporation has entered into a definitive agreement to sell its consumer audio business, Sound United, to Harman International Industries for $350 million in cash, subject to adjustments.

Masimo Corporation reports a cybersecurity incident that has disrupted manufacturing operations and order fulfillment processes.

Masimo Corporation announced its first quarter 2025 financial results, showcasing double-digit revenue growth and significant earnings growth, while also updating its full-year 2025 guidance to reflect the impact of new tariffs.

Masimo Corporation has agreed to sell its Sound United consumer audio business to Harman International for $350 million in cash, focusing on its core professional healthcare segment.

Masimo Corporation held its annual meeting on April 29, 2025, where stockholders elected directors, ratified the selection of Grant Thornton LLP as the independent auditor, and approved executive compensation.

Masimo announces positive Q4 and full-year 2024 financial results, driven by healthcare revenue growth, and updates its full-year 2025 guidance, focusing on its core healthcare business.

Masimo Corporation's board approved amended bylaws, including changes to special meeting rights, amendment thresholds, and director nomination timelines, while also scheduling the 2025 annual meeting for April 29, 2025.

Masimo Corporation (MASI) announced the termination of employment of Tom McClenahan, its Executive Vice President, General Counsel, and Corporate Secretary, effective February 6, 2025.

Robert Chapek has resigned from Masimo Corporation's Board of Directors, effective at the company's 2025 annual meeting.

Masimo Corporation announces the appointment of Catherine Szyman as its new Chief Executive Officer, effective February 12, 2025, with Michelle Brennan transitioning to Chairman of the Board.

Masimo reported preliminary full-year 2024 healthcare revenue of $1.395 billion, a 10% constant currency increase, and provided 2025 guidance with improved non-GAAP operating margin targets.

Masimo Corporation terminated the employment of its Executive Vice President, Business Development, as part of a strategic refocus on its core healthcare business.

Masimo Corporation has formalized the appointment of Michelle Brennan as interim CEO with a six-month employment agreement, including a base salary, potential bonus, and equity award.

Masimo Corporation announced positive third-quarter results driven by its healthcare segment, and increased its full-year non-GAAP operating margin and EPS guidance.

Masimo Corporation reaffirms its non-GAAP financial guidance for Q3 and full-year 2024, while also announcing the termination of CEO Joe Kiani, effective immediately.

Masimo Corporation has appointed Timothy J. Scannell and Wendy E. Lane as independent directors, increasing the board size to eight members.